Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial

We conducted a clinical trial to assess the safety and putative efficacy of an additional human rabies immune globulin (HRIG; KEDRAB) versus an older product (Comparator, HyperRAB S/D® [Grifols]) and determine whether HRIG interferes with development of endogenous antibodies versus Comparator, when...

Descripción completa

Detalles Bibliográficos
Autores principales: Matson, Mark A., Schenker, Eran, Stein, Michal, Zamfirova, Vladislava, Nguyen, Huy-Binh, Bergman, Garrett E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062421/
https://www.ncbi.nlm.nih.gov/pubmed/31549899
http://dx.doi.org/10.1080/21645515.2019.1656967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062421/
https://www.ncbi.nlm.nih.gov/pubmed/31549899
http://dx.doi.org/10.1080/21645515.2019.1656967

Ejemplares similares